Clinical Trials on Carbohydrate Intolerance in Hong Kong
Total 20 results
-
Chinese University of Hong KongUnknownDiabetes | Glucose Intolerance | Impaired Glucose Tolerance (IGT) | Impaired Fasting Glucose (IFG)China
-
Elaine ChowMerck KGaA, Darmstadt, GermanyNot yet recruiting
-
The University of Hong KongTung Wah Eastern HospitalCompleted
-
The University of Hong KongRecruiting
-
The University of Hong KongNot yet recruitingObesity | PreDiabetes | Type 2 DiabetesHong Kong
-
The University of Hong KongActive, not recruitingPre-diabetesHong Kong
-
Hong Kong Children's HospitalRecruitingGlycogen Storage Disease Type IBHong Kong
-
The University of Hong KongSuspendedPreDiabetes | Insulin SensitivityHong Kong
-
Chinese University of Hong KongSugardown Company LimitedCompletedPre-DiabetesHong Kong
-
Chinese University of Hong KongUnknownPrediabetes | Cardiovascular Risk FactorsChina
-
Chinese University of Hong KongRecruiting
-
Forest LaboratoriesCompleted
-
Dr. Prayuth SudathipMedicines for Malaria VentureCompletedMalaria, Vivax | G6PD DeficiencyThailand
-
Green Cross CorporationCompletedMucopolysaccharidosis IIKorea, Republic of
-
University of OxfordBayerCompletedCoronary Heart Disease | Acute Coronary Syndrome | Impaired Glucose Tolerance | Type 2 Diabetes Mellitus (T2DM)China, Hong Kong
-
GlaxoSmithKlineCompletedHypertensionUnited States
-
Theravance BiopharmaCompletedParkinson Disease | Orthostatic Hypotension | Neurogenic Orthostatic Hypotension | Hypotension, Orthostatic | Pure Autonomic Failure | Multiple System Atrophy (MSA) With Orthostatic Hypotension | Pure Autonomic Failure With Orthostatic Hypotension | Parkinson Disease With Orthostatic HypotensionUnited States
-
Genzyme, a Sanofi CompanyRecruitingMucopolysaccharidosis I (MPS I)Croatia, United States, Argentina, Australia, Belgium, Brazil, Canada, Denmark, France, Hong Kong, India, Indonesia, Korea, Republic of, Kuwait, Lebanon, Malaysia, Netherlands, Pakistan, Philippines, Poland, Saudi Arabia, Singapore, Slovaki... and more
-
Genzyme, a Sanofi CompanyRecruitingGlycogen Storage Disease Type II | Pompe DiseaseHungary, Croatia, Serbia, United States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Denmark, France, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Japan, Jordan, Korea, Republic of, Kuwait and more
-
Theravance BiopharmaCompletedSymptomatic Neurogenic Orthostatic HypotensionUnited States, Spain, Israel, Hungary, Portugal, Australia, Canada, Germany, Russian Federation, Estonia, France, Italy, United Kingdom, Denmark, Poland, New Zealand, Austria, Bulgaria, Ukraine